🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsRybelsus on an empty stomach is ruining my mornings — May 2025 Page 2

Rybelsus on an empty stomach is ruining my mornings — May 2025

jason_sac26 Mon, May 26, 2025 at 4:06 AM 7 replies 1,468 viewsPage 2 of 2
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
May 27, 2025 at 12:28 PM#6
HPLC_Greg said:
The OASIS programme put 50mg oral in the same territory as 2.4mg injectable — around 15% mean weight loss — but it needed a dose 20 times larger to…

I do not accept that the fasting window is a minor inconvenience. Adherence data on daily orals with timing requirements is consistently worse than weekly injections, and a drug you take imperfectly is a lower dose than the one on the box.

16 11SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 13 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
May 28, 2025 at 1:24 AM#7

Adding the numbers, since they settle part of this. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

15 10Dr.GutHealth, amsterdam_pete, LondonLisa and 12 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
May 28, 2025 at 2:21 PM#8
Dr.MetabolicMD said:
I do not accept that the fasting window is a minor inconvenience.

Coming at Dr.MetabolicMD’s question from a different direction. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

14 9MASHdoc_SA, GenomicsKate, Dr.ObesityMed and 11 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
May 29, 2025 at 3:18 AM#9

Following on from carl_compliance — and this may be the naive question:

How much of the oral variability is the SNAC absorption window and how much is dose, because the two get conflated constantly?

13 8oliver_london, tane_welly, Dr.PathRoch and 10 others
Reply Quote Save Share Report
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
May 31, 2025 at 5:29 PM#10

Reporting back.

Update — I went back to the injectable. Not because the tablet did not work, but because the fasting window and my mornings were never going to agree.

25 23Dr.PulmRoch, maya_sedona, stefan_berlin and 22 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register